Browse > Article
http://dx.doi.org/10.7314/APJCP.2013.14.4.2477

Prognostic Significance of 18F-fluorodeoxyglucose Positron Emission Tomography (PET)-based Parameters in Neoadjuvant Chemoradiation Treatment of Esophageal Carcinoma  

Ma, Jin-Bo (Department of Radiation Oncology, Yantai Yuhuangding Hospital, School of Medicine)
Chen, Er-Cheng (Department of Radiation Oncology, Yantai Yuhuangding Hospital, School of Medicine)
Song, Yi-Peng (Department of Radiation Oncology, Yantai Yuhuangding Hospital, School of Medicine)
Liu, Peng (Department of Radiation Oncology, Yantai Yuhuangding Hospital, School of Medicine)
Jiang, Wei (Department of Radiation Oncology, Yantai Yuhuangding Hospital, School of Medicine)
Li, Ming-Huan (Department of Radiation Oncology, Shandong Cancer Hospital & Institute)
Yu, Jin-Ming (Department of Radiation Oncology, Shandong Cancer Hospital & Institute)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.14, no.4, 2013 , pp. 2477-2481 More about this Journal
Abstract
Aims and Background: The purpose of the research was to study the prognostic value of tumor 18F-FDG PET-based parameters in neoadjuvant chemoradiation for patients with squamous esophageal carcinoma. Methods: Sixty patients received chemoradiation therapy followed by esophagectomy and two 18FDG-PET examinations at pre- and post-radiation therapy. PET-based metabolic-response parameters were calculated based on histopathologic response. Linear regression correlation and Cox proportional hazards models were used to determine prognostic value of all PET-based parameters with reference to overall survival. Results: Sensitivity (88.2%) and specificity (86.5%) of a percentage decrease of SUVmax were better than other PET-based parameters for prediction of histopathologic response. Only percentage decrease of SUVmax and tumor length correlated with overall survival time (linear regression coefficient ${\beta}$: 0.704 and 0.684, P<0.05). The Cox proportional hazards model indicated higher hazard ratio (HR=0.897, P=0.002) with decrease of SUVmax compared with decrease of tumor size (HR=0.813, P=0.009). Conclusion: Decrease of SUVmax and tumor size are significant prognostic factors in chemoradiation of esophageal carcinoma.
Keywords
Esophageal cancer; chemoradiation; positron emission tomography; prognostic factors;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Akutsu Y, Matsubara H, Shuto K, et al (2009). Clinical and pathologic evaluation of the effectiveness of neoadjuvant chemoradiation therapy in advanced esophageal cancer patients. World J Surg, 33, 1002-9.   DOI
2 Becker K, Mueller JD, Schulmacher C, et al (2003). Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy. Cancer, 98, 1521-30.   DOI   ScienceOn
3 Cescon DW, Hopkins JP, Bradbury PA, et al (2009). Epidemiology of Esophageal Cancer: Molecular. Esophageal cancer: principles and practice, 93.
4 Chang F, Deere H, Mahadeva U, George S (2008). Histopathologic examination and reporting of esophageal carcinomas following preoperative neoadjuvant therapy: practical guidelines and current issues. Am J Clin Pathol, 129, 252-62.   DOI   ScienceOn
5 Choi NC, Fischman AJ, Niemierko A, et al (2002). Doseresponse relationship between probability of pathologic tumor control and glucose metabolic rate measured with FDG PET after preoperative chemoradiotherapy in locally advanced non-small-cell lung cancer. Int J Radiat Oncol Biol Phys, 54, 1024-35.   DOI   ScienceOn
6 DeVita VT, Lawrence TS, Rosenberg SA. DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology. Lippincott Williams & Wilkins 2008.
7 Gillham CM, Lucey JA, Keogan M, et al (2006). (18)FDG uptake during induction chemoradiation for oesophageal cancer fails to predict histomorphological tumour response. Br J Cancer, 95, 1174-9.   DOI   ScienceOn
8 Heilmann HP, Molls M, Nieder C, et al. Radiation Oncology: An Evidence-based Approach. Springer 2008.
9 Hiyoshi Y, Watanabe M, Imamura Y, et al (2009). The relationship between the glucose transporter type 1 expression and F-fluorodeoxyglucose uptake in esophageal squamous cell carcinoma. Oncology, 76, 286-92.   DOI   ScienceOn
10 Javeri H, Xiao L, Rohren E, et al (2009a). Influence of the baseline 18F-fluoro-2-deoxy-D-glucose positron emission tomography results on survival and pathologic response in patients with gastroesophageal cancer undergoing chemoradiation. Cancer, 115, 624-30.   DOI   ScienceOn
11 Javeri H, Xiao L, Rohren E, et al (2009b). The higher the decrease in the standardized uptake value of positron emission tomography after chemoradiation, the better the survival of patients with gastroesophageal adenocarcinoma. Cancer, 115, 5184-92.   DOI   ScienceOn
12 Roedl JB, Harisinghani MG, Colen RR, et al (2008). Assessment of treatment response and recurrence in esophageal carcinoma based on tumor length and standardized uptake value on positron emission tomography-computed tomography. Ann Thorac Surg, 86, 1131-8.   DOI   ScienceOn
13 Jingu K, Kaneta T, Nemoto K, et al (2010). (18) F-fluorodeoxyglucose positron emission tomography immediately after chemoradiotherapy predicts prognosis in patients with locoregional postoperative recurrent esophageal cancer. Int J Clin Oncol, 15, 184-90.   DOI
14 Kim MK, Ryu JS, Kim SB, et al (2007). Value of complete metabolic response by (18)F-fluorodeoxyglucose-positron emission tomography in oesophageal cancer for prediction of pathologic response and survival after preoperative chemoradiotherapy. Eur J Cancer, 43, 1385-91.   DOI   ScienceOn
15 Klaeser B, Nitzsche E, Schuller JC, et al (2009). Limited predictive value of FDG-PET for response assessment in the preoperative treatment of esophageal cancer: results of a prospective multi-center trial (SAKK 75/02). Onkologie, 32, 724-30.   DOI   ScienceOn
16 Schmidt M, Bollschweiler E, Dietlein M, et al (2009). Mean and maximum standardized uptake values in [18F]FDGPET for assessment of histopathological response in oesophageal squamous cell carcinoma or adenocarcinoma after radiochemotherapy. Eur J Nucl Med Mol Imaging, 36, 735-44.   DOI
17 Suzuki A, Xiao L, Hayashi Y, et al (2011). Prognostic significance of baseline positron emission tomography and importance of clinical complete response in patients with esophageal or gastroesophageal junction cancer treated with definitive chemoradiotherapy. Cancer, 117, 4823-33.   DOI   ScienceOn
18 Tong DK, Law S, Kwong DL, et al (2010). Histological regression of squamous esophageal carcinoma assessed by percentage of residual viable cells after neoadjuvant chemoradiation is an important prognostic factor. Ann Surg Oncol, 17, 2184-92.   DOI